{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-006042","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2024-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.058558+00:00","generated_at":"2026-06-06T19:10:32.130754+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sagimet Biosciences reports preliminary cash of $94.9M as of Dec 31, 2023","bullets":["Cash, cash equivalents and short-term investments estimated at ~$94.9M.","Amount is unaudited, prepared by management and subject to completion of closing procedures.","Actual year-end 2023 results may differ; will be included in Form 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-006042","json":"https://secwatch.observer/filing/0001104659-24-006042.json","markdown":"https://secwatch.observer/filing/0001104659-24-006042.md","text":"https://secwatch.observer/filing/0001104659-24-006042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924006042/0001104659-24-006042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924006042/tm2333216d9_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T19:10:32.130754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}